The Daily Dose – The stem cell vetting continues
US National Institutes of Health (NIH) director Francis Collins yesterday announced the addition of eight new human embryonic stem cells lines to the NIH’s registry, bringing up the total number of stem cell lines available for use in federally funded research to 75. The new lines were developed at the University of Connecticut, the University of New South Wales in Australia, the Whitehead Institute for Biomedical Research, and Advanced Cell Technology, a Santa Monica biotech company. Read more
Recent comments
Real-time tissue analysis could guide brain tumor surgery
Bundled RNA balls silence brain cancer gene expression
Ebola outbreak in West Africa lends urgency to recently-funded research